This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ahmed M.S., Abed M., Voelkl J., Lang F.: Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol. 14, 244 (2013)AhmedM.S.AbedM.VoelklJ.LangF.Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfateBMC Nephrol.14244201310.1186/1471-2369-14-244422828524188099Search in Google Scholar
Anders H.J., Andersen K., Stecher B.: The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 83, 1010–1016 (2013)AndersH.J.AndersenK.StecherB.The intestinal microbiota, a leaky gut, and abnormal immunity in kidney diseaseKidney Int.8310101016201310.1038/ki.2012.44023325079Search in Google Scholar
Arumugam M., Bork P. et al.: Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011)ArumugamM.BorkP.Enterotypes of the human gut microbiomeNature473174180201110.1038/nature09944372864721508958Search in Google Scholar
Baeckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I.: The gut microbiota as an environmental factor that regulates fat storage. Proc Nati Acad Sci USA,101,15718–15723(2004)BaeckhedF.DingH.WangT.HooperL.V.KohG.Y.NagyA.SemenkovichC.F.GordonJ.I.The gut microbiota as an environmental factor that regulates fat storageProc Nati Acad Sci USA1011571815723200410.1073/pnas.040707610152421915505215Search in Google Scholar
Bossola M., Luciani G., Rosa F., Tazza L.: Appetite and Gastrointestinal Symptoms in Chronic Hemodialysis Patients. J. Renl. Nutr. 21, 448–454 (2011)BossolaM.LucianiG.RosaF.TazzaL.Appetite and Gastrointestinal Symptoms in Chronic Hemodialysis PatientsJ. Renl. Nutr.21448454201110.1053/j.jrn.2010.09.00321239186Search in Google Scholar
Carrero J.J., Stenvinkel P.: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin. J. Am. Soc. Nephrol. 4, 49–55 (2009)CarreroJ.J.StenvinkelP.Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposalClin. J. Am. Soc. Nephrol.44955200910.2215/CJN.0272040919996005Search in Google Scholar
Castillo-Rodriguez E., Sanchez-Niño M.D. et al.: Impact of altered intestinal microbiota on chronic kidney disease progression. Toxins, 10, doi: 10.3390/toxins10070300 (2018)Castillo-RodriguezE.Sanchez-NiñoM.D.Impact of altered intestinal microbiota on chronic kidney disease progressionToxins10doi:10.3390/toxins100703002018607098930029499Open DOISearch in Google Scholar
Claro L.M., Pécoits-Filho R. et al.: The impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney disease. Toxins, 10, doi: 10.3390/toxins10100384 (2018)ClaroL.M.Pécoits-FilhoR.The impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney diseaseToxins10doi:10.3390/toxins101003842018621531030249039Open DOISearch in Google Scholar
Costea P.I., Bork P. et al.: Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018)CosteaP.I.BorkP.Enterotypes in the landscape of gut microbial community compositionNat. Microbiol.3816201810.1038/s41564-017-0072-8583204429255284Search in Google Scholar
Cummings J.H., Macfarlane G.T.: Collaborative JPEN-Clinical Nutrition Scientific Publications Role of intestinal bacteria in nutrient metabolism. JPEN-Parenter Enter. 21, 357–365 (1997)CummingsJ.H.MacfarlaneG.T.Collaborative JPEN-Clinical Nutrition Scientific Publications Role of intestinal bacteria in nutrient metabolismJPEN-Parenter Enter.21357365199710.1177/01486071970210063579406136Search in Google Scholar
DeFronzo R.A., Alvestrand A., Smith D., Hendler R., Hendler E., Wahren J.: Insulin resistance in uremia. J. Clin. Invest. 67, 563–568 (1981)DeFronzoR.A.AlvestrandA.SmithD.HendlerR.HendlerE.WahrenJ.Insulin resistance in uremiaJ. Clin. Invest.67563568198110.1172/JCI1100673706007007440Search in Google Scholar
Doron S., Snydman D.R.: Risk and Safety of Probiotics. Clin. Infect. Dis. 60, 129–34 (2015)DoronS.SnydmanD.R.Risk and Safety of ProbioticsClin. Infect. Dis.6012934201510.1093/cid/civ085449023025922398Search in Google Scholar
Esgalhado M., Kemp J.A., Damasceno N.R., Fouque D., Mafra D.: Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. Future Microbiol. 12, 1413–1425 (2017)EsgalhadoM.KempJ.A.DamascenoN.R.FouqueD.MafraD.Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney diseaseFuture Microbiol.1214131425201710.2217/fmb-2017-005929027814Search in Google Scholar
Fujii H., Goto S., Fukagawa M.: Role of uremic toxins for kidney, cardiovascular, and bone dysfunction. Toxins, 10, doi: 10.3390/toxins10050202 (2018)FujiiH.GotoS.FukagawaM.Role of uremic toxins for kidney, cardiovascular, and bone dysfunctionToxins10doi:10.3390/toxins100502022018598325829772660Open DOISearch in Google Scholar
George Kerry R., Patra J.K., Gouda S., Park Y., Shin H.S., Das G.: Benefaction of probiotics for human health: A review. J. Food Drug. Anal. 26, 927–939 (2018)George KerryR.PatraJ.K.GoudaS.ParkY.ShinH.S.DasG.Benefaction of probiotics for human health: A reviewJ. Food Drug. Anal.26927939201810.1016/j.jfda.2018.01.00229976412Search in Google Scholar
Gerson L.B.: Causes of gastrointestinal hemorrhage in patients with chronic renal failure. Gastroenterology 145, 895–897 (2013)GersonL.B.Causes of gastrointestinal hemorrhage in patients with chronic renal failureGastroenterology145895897201310.1053/j.gastro.2013.08.02923973676Search in Google Scholar
Goto S., Fujii H., Hamada Y., Yoshiya K., Fukagawa M.: Association Between Indoxyl Sulfate and Skeletal Resistance in Hemodialysis Patients. Ther. Apher. Dial. 14, 417–423 (2010)GotoS.FujiiH.HamadaY.YoshiyaK.FukagawaM.Association Between Indoxyl Sulfate and Skeletal Resistance in Hemodialysis PatientsTher. Apher. Dial.14417423201010.1111/j.1744-9987.2010.00813.x20649763Search in Google Scholar
Cigarran Guldris S., Gonzalez Parra E., Cases Amenós A.: Gut microbiota in chronic kidney disease. Nefrología (English Edition) 37, 9–19 (2017)Cigarran GuldrisS.Gonzalez ParraE.Cases AmenósA.Gut microbiota in chronic kidney diseaseNefrología (English Edition)37919201710.1016/j.nefroe.2017.01.017Search in Google Scholar
Hoyles L., Dumas M.E. et al.: Metabolic retroconversion of tri-methylamine N-oxide and the gut microbiota. Microbiome 6, 73 (2018)HoylesL.DumasM.E.Metabolic retroconversion of tri-methylamine N-oxide and the gut microbiotaMicrobiome673201810.1186/s40168-018-0461-0590924629678198Search in Google Scholar
Hsu C.C., Lu Y.C., Chiu C.A., Yu T.H., Hung W.C., Wang C.P., Lu L.F., Chung F.M., Lee Y.J., Tsai I.T: Levels of indoxyl sulfate are associated with severity of coronary atherosclerosis. Clin. Invest. Med. 36, E42–49 (2013)HsuC.C.LuY.C.ChiuC.A.YuT.H.HungW.C.WangC.P.LuL.F.ChungF.M.LeeY.J.TsaiI.TLevels of indoxyl sulfate are associated with severity of coronary atherosclerosisClin. Invest. Med.36E4249201310.25011/cim.v36i1.1940423374599Search in Google Scholar
Jia L., Jia Q., Yang J., Jia R., Zhang H.; Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis. Kidney Blood Press. Res 43,1623–1635 (2018)JiaL.JiaQ.YangJ.JiaR.ZhangH.Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysisKidney Blood Press. Res4316231635201810.1159/00049467730380555Search in Google Scholar
Kelly J.T., Palmer S.C., Wai S.N., Ruospo M., Carrero J.J., Campbell K.L., Strippoli G.F.M.: Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies. Clin. J. Am. Soc. Nephrol. 12, 272–279 (2017)KellyJ.T.PalmerS.C.WaiS.N.RuospoM.CarreroJ.J.CampbellK.L.StrippoliG.F.M.Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studiesClin. J. Am. Soc. Nephrol.12272279201710.2215/CJN.06190616529333527932391Search in Google Scholar
Koppe L., Fouque D., Soulage C.O.: The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease. Toxins, 10, doi: 10.3390/toxins10040155 (2018)KoppeL.FouqueD.SoulageC.O.The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney diseaseToxins10doi:10.3390/toxins100401552018592332129652797Open DOISearch in Google Scholar
Koppe L., Mafra D., Fouque D.: Probiotics and chronic kidney disease. Kidney Int. 88, 958–966 (2015)KoppeL.MafraD.FouqueD.Probiotics and chronic kidney diseaseKidney Int.88958966201510.1038/ki.2015.25526376131Search in Google Scholar
Koppe L., Pelletier C.C., Alix P.M., Kalbacher E., Fouque D., Soulage C.O., Guebre-Egziabher F.: Insulin resistance in chronic kidney disease: new lessons from experimental models. Nephrol. Dial. Transplant 29, 1666–1674 (2014)KoppeL.PelletierC.C.AlixP.M.KalbacherE.FouqueD.SoulageC.O.Guebre-EgziabherF.Insulin resistance in chronic kidney disease: new lessons from experimental modelsNephrol. Dial. Transplant2916661674201410.1093/ndt/gft43524286973Search in Google Scholar
Koppe L., Soulage C.O. et al.: p-Cresyl sulfate promotes insulin resistance associated with CKD. J. Am. Soc. Nephrol. 24, 88–99 (2013)KoppeL.SoulageC.O.p-Cresyl sulfate promotes insulin resistance associated with CKDJ. Am. Soc. Nephrol.248899201310.1681/ASN.2012050503353721523274953Search in Google Scholar
Leong S.C., Sirich T.L.: Indoxyl Sulfate-review of toxicity and therapeutic strategies. Toxins 8, E358 (2016)LeongS.C.SirichT.L.Indoxyl Sulfate-review of toxicity and therapeutic strategiesToxins8E358201610.3390/toxins8120358519855227916890Search in Google Scholar
Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I.: Obesity alters gut microbial ecology. Proc. Nat. Acad. Sci. USA 102, 11070–11075 (2005)LeyR.E.BäckhedF.TurnbaughP.LozuponeC.A.KnightR.D.GordonJ.I.Obesity alters gut microbial ecologyProc. Nat. Acad. Sci. USA1021107011075200510.1073/pnas.0504978102117691016033867Search in Google Scholar
Lin C.J., Wu V., Wu P.C., Wu, C.J.: Meta-Analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 10, e0132589 (2015)LinC.J.WuV.WuP.C.WuC.J.Meta-Analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failurePLoS One10e0132589201510.1371/journal.pone.0132589450175626173073Search in Google Scholar
Liu B., Luo F., Luo X., Duan S., Gong Z., Peng J.: Metabolic enzyme system and transport pathways in chronic kidney diseases. Curr. Drug. Metab. 19, 568–576 (2018)LiuB.LuoF.LuoX.DuanS.GongZ.PengJ.Metabolic enzyme system and transport pathways in chronic kidney diseasesCurr. Drug. Metab.19568576201810.2174/138920021966618010314344829299983Search in Google Scholar
McCaleb M.L., Izzo M.S., Lockwood D.H.: Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J. Clin. Invest. 75, 391–396 (1985)McCalebM.L.IzzoM.S.LockwoodD.H.Characterization and partial purification of a factor from uremic human serum that induces insulin resistanceJ. Clin. Invest.75391396198510.1172/JCI1117124235023882760Search in Google Scholar
Meijers B., Farré R., Dejongh S., Vicario M., Evenepoel P.: Intestinal barrier function in chronic kidney disease. Toxins, 10, doi: 10.3390/toxins10070298 (2018)MeijersB.FarréR.DejonghS.VicarioM.EvenepoelP.Intestinal barrier function in chronic kidney diseaseToxins10doi:10.3390/toxins100702982018607121230029474Open DOISearch in Google Scholar
Meropol S.B., Edwards A.: Development of the infant intestinal microbiome: a bird’s eye view of a complex process. Birth Defects Res. C Embryo. Today 105, 228–239 (2015)MeropolS.B.EdwardsA.Development of the infant intestinal microbiome: a bird’s eye view of a complex processBirth Defects Res. C Embryo. Today105228239201510.1002/bdrc.21114563738826663826Search in Google Scholar
Mishima E., Abe T. et al.: Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model. Am. J. Physiol. Renal Physiol. 315, F824–833 (2018)MishimaE.AbeT.Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse modelAm. J. Physiol. Renal Physiol.315F824833201810.1152/ajprenal.00314.201729167170Search in Google Scholar
Moraes C., Borges N.A., Mafra D.: Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?. Eur. J. Nut. 55, 1813–1821 (2016)MoraesC.BorgesN.A.MafraD.Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?Eur. J. Nut.5518131821201610.1007/s00394-015-1138-026830416Search in Google Scholar
Nallu A., Sharma S., Ramezani A., Muralidharan J., Raj D.: Gut microbiome in CKD: challenges and opportunities. Transl. Res. 179, 24–37 (2017)NalluA.SharmaS.RamezaniA.MuralidharanJ.RajD.Gut microbiome in CKD: challenges and opportunitiesTransl. Res.1792437201710.1016/j.trsl.2016.04.007508644727187743Search in Google Scholar
Nangaku M., Mimura I., Yamaguchi J., Higashijima Y., Wada T., Tanaka T.: Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients. J. Ren. Nutr. 25, 160–163 (2015)NangakuM.MimuraI.YamaguchiJ.HigashijimaY.WadaT.TanakaT.Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patientsJ. Ren. Nutr.25160163201510.1053/j.jrn.2014.10.01125556149Search in Google Scholar
Pan W., Kang, Y.: Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies. Int. Urol. Nephrol. 50, 289–299 (2018)PanW.KangY.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategiesInt. Urol. Nephrol.50289299201810.1007/s11255-017-1689-528849345Search in Google Scholar
Pawlak, J., Derlacz R.A.: Mechanizm powstawania oporności na insulinę w tkankach obwodowych. Postępy Biochemii 57, 200–206 (2011)PawlakJ.DerlaczR.A.Mechanizm powstawania oporności na insulinę w tkankach obwodowychPostępy Biochemii572002062011Search in Google Scholar
Piñero-Lambea C., Ruano-Gallego D., Fernández L.Á.: Engineered bacteria as therapeutic agents. Curr. Opin. Biotechnol. 35, 94–102 (2015)Piñero-LambeaC.Ruano-GallegoD.FernándezL.Á.Engineered bacteria as therapeutic agentsCurr. Opin. Biotechnol.3594102201510.1016/j.copbio.2015.05.00426070111Search in Google Scholar
Poesen R., Evenepoel P., De Loor H., Delcour J.A., Courtin C.M., Kuypers D., Augustijns P., Verbeke K., Meijers B.: The influence of prebiotic arabinoxylan oligosaccharides on microbiota derived uremic retention solutes in patients with chronic kidney disease: a randomized controlled trial. PLoS One 11, e0153893(2016)PoesenR.EvenepoelP.De LoorH.DelcourJ.A.CourtinC.M.KuypersD.AugustijnsP.VerbekeK.MeijersB.The influence of prebiotic arabinoxylan oligosaccharides on microbiota derived uremic retention solutes in patients with chronic kidney disease: a randomized controlled trialPLoS One11e0153893201610.1371/journal.pone.0153893483973727100399Search in Google Scholar
Prokopienko A.J., Nolin T.D.: Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease. Expert Rev. Clin. Pharmacol. 11, 71–82 (2018)ProkopienkoA.J.NolinT.D.Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney diseaseExpert Rev. Clin. Pharmacol.117182201810.1080/17512433.2018.1378095597926928905671Search in Google Scholar
Qin, J., Wang J. et al.: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010)QinJ.WangJ.A human gut microbial gene catalogue established by metagenomic sequencingNature4645965201010.1038/nature08821377980320203603Search in Google Scholar
Krishnamurthy V.M., Wei G., Baird B.C., Murtaugh M., Chonchol M.B., Raphael K.L., Greene T., Beddhu S.: High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 81, 300–306 (2012)KrishnamurthyV.M.WeiG.BairdB.C.MurtaughM.ChoncholM.B.RaphaelK.L.GreeneT.BeddhuS.High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney diseaseKidney Int.81300306201210.1038/ki.2011.355470485522012132Search in Google Scholar
Rhee E.P., Gerszten R.E. et al.: A combined epidemiologic and metabolomic approach improves CKD prediction, J. Am. Soc. Nephrol. 24, 1330–1338 (2013)RheeE.P.GersztenR.E.A combined epidemiologic and metabolomic approach improves CKD predictionJ. Am. Soc. Nephrol.2413301338201310.1681/ASN.2012101006373670223687356Search in Google Scholar
Rigalleau V., Blanchetier V., Combe C., Guillot C., Deleris G., Aubertin J., Aparicio M., Gin H.: A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am. J. Clin. Nutr. 65, 1512–1516 (1997)RigalleauV.BlanchetierV.CombeC.GuillotC.DelerisG.AubertinJ.AparicioM.GinH.A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patientsAm. J. Clin. Nutr.6515121516199710.1093/ajcn/65.5.15129129485Search in Google Scholar
Sabatino A., Regolisti G., Brusasco I., Cabassi A., Morabito S., Fiaccadori E.: Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol. Dial. Transplant. 30, 924–933 (2015)SabatinoA.RegolistiG.BrusascoI.CabassiA.MorabitoS.FiaccadoriE.Alterations of intestinal barrier and microbiota in chronic kidney diseaseNephrol. Dial. Transplant.30924933201510.1093/ndt/gfu28725190600Search in Google Scholar
Salmean Y.A., Segal M.S., Langkamp-Henken B., Canales M.T., Zello G.A., Dahl W.J.: Foods with added fiber lower serum creatinine levels in patients with chronic kidney disease. J. Ren. Nutr. 23, e29–32 (2013)SalmeanY.A.SegalM.S.Langkamp-HenkenB.CanalesM.T.ZelloG.A.DahlW.J.Foods with added fiber lower serum creatinine levels in patients with chronic kidney diseaseJ. Ren. Nutr.23e2932201310.1053/j.jrn.2012.04.00222739658Search in Google Scholar
Sato B., Murohara T. et al.: Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. Am. J. Cardiol. 111, 712–716 (2013)SatoB.MuroharaT.Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunctionAm. J. Cardiol.111712716201310.1016/j.amjcard.2012.11.02523228923Search in Google Scholar
Sircana A., De Michieli F., Parente R., Framarin L., Leone N., Berrutti M., Paschetta E., Bongiovanni D., Musso G.: Gut microbiota, hypertension and chronic kidney disease: recent advances. Pharmacol. Res. doi: 10.1016/j.phrs.2018.01.013 (2018)SircanaA.De MichieliF.ParenteR.FramarinL.LeoneN.BerruttiM.PaschettaE.BongiovanniD.MussoG.Gut microbiota, hypertension and chronic kidney disease: recent advancesPharmacol. Res.doi:10.1016/j.phrs.2018.01.013201829378252Open DOISearch in Google Scholar
Soulage C.O., Koppe L., Fouque D.: Protein-bound uremic toxins... new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease. J. Ren. Nutr. 23, 464–466 (2013)SoulageC.O.KoppeL.FouqueD.Protein-bound uremic toxins... new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney diseaseJ. Ren. Nutr.23464466201310.1053/j.jrn.2013.06.00323938300Search in Google Scholar
Spoto B., Pisano A., Zoccali C.: Insulin resistance in chronic kidney disease: a systematic review. Am. J. Physiol. Renal. Physiol. 311, 1087–1108 (2016)SpotoB.PisanoA.ZoccaliC.Insulin resistance in chronic kidney disease: a systematic reviewAm. J. Physiol. Renal. Physiol.31110871108201610.1152/ajprenal.00340.201627707707Search in Google Scholar
Strzępa A., Szczepanik M.: Wpływ naturalnej flory jelitowej na odpowiedź immunologiczną. Postepy Hig. Med. Dosw. 67, 908–920 (2013)StrzępaA.SzczepanikM.Wpływ naturalnej flory jelitowej na odpowiedź immunologicznąPostepy Hig. Med. Dosw.67908920201310.5604/17322693.106456324018457Search in Google Scholar
Tojo R., Suarez A., Clemente M.G., de los Reyes-Gavilan C.G., Margolles A., Gueimonde M., Ruas-Madiedo P.: Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 20, 15163–15176 (2014)TojoR.SuarezA.ClementeM.G.de los Reyes-GavilanC.G.MargollesA.GueimondeM.Ruas-MadiedoP.Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasisWorld J. Gastroenterol.201516315176201410.3748/wjg.v20.i41.15163422325125386066Search in Google Scholar
Tsai M.L., Hsieh I.C., Hung C.C., Chen C.C.: Serum free indoxyl sulfate associated with in-stent restenosis after coronary artery stentings. Cardiovasc. Toxicol. 15, 52–60 (2015)TsaiM.L.HsiehI.C.HungC.C.ChenC.C.Serum free indoxyl sulfate associated with in-stent restenosis after coronary artery stentingsCardiovasc. Toxicol.155260201510.1007/s12012-014-9270-225539627Search in Google Scholar
Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006)TurnbaughP.J.LeyR.E.MahowaldM.A.MagriniV.MardisE.R.GordonJ.I.An obesity-associated gut microbiome with increased capacity for energy harvestNature44410271031200610.1038/nature0541417183312Search in Google Scholar
Vaziri N.D., Goshtasbi N., Yuan J., Jellbauer S., Moradi H., Raffatellu M., Kalantar-Zadeh K.: Uremic Plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am. J. Nephrol. 36, 438–443 (2012)VaziriN.D.GoshtasbiN.YuanJ.JellbauerS.MoradiH.RaffatelluM.Kalantar-ZadehK.Uremic Plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epitheliumAm. J. Nephrol.36438443201210.1159/000343886372530623128155Search in Google Scholar
Vaziri N.D., Yuan J., Norris K.: Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am. J. Nephrol. 37, 1–6 (2013)VaziriN.D.YuanJ.NorrisK.Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney diseaseAm. J. Nephrol.3716201310.1159/000345969368657123258127Search in Google Scholar
Velasquez M.T., Centron P., Barrows I., Dwivedi R., Raj D.S.: Gut microbiota and cardiovascular uremic toxicities. Toxins, 10, doi: 10.3390/toxins10070287 (2018)VelasquezM.T.CentronP.BarrowsI.DwivediR.RajD.S.Gut microbiota and cardiovascular uremic toxicitiesToxins10doi:10.3390/toxins100702872018607126829997362Open DOISearch in Google Scholar
Watanabe K., Tominari T., Hirata M., Matsumoto C., Hirata J., Murphy G., Nagase H., Miyaura C., Inada M.: Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption. FEBS Open Bio 7, 1178–1185 (2017)WatanabeK.TominariT.HirataM.MatsumotoC.HirataJ.MurphyG.NagaseH.MiyauraC.InadaM.Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorptionFEBS Open Bio711781185201710.1002/2211-5463.12258553699328781957Search in Google Scholar
Wong J., Piceno Y.M., DeSantis T.Z., Pahl M., Andersen G.L., Vaziri, N.D.: Expansion of Urease – and uricase-containing, indole – and p-Cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am. J. Nephrol. 9, 230–237 (2014)WongJ.PicenoY.M.DeSantisT.Z.PahlM.AndersenG.L.VaziriN.D.Expansion of Urease – and uricase-containing, indole – and p-Cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRDAm. J. Nephrol.9230237201410.1159/000360010404926424643131Search in Google Scholar
Yacoub R., Kaji D., Patel S.N., Simoes P.K., Busayavalasa D., Nadkarni G.N., He J.C., Coca S.G., Uribarri J.: Association between probiotic and yogurt consumption and kidney disease: insights from NHANES. Nutr. J. 15, 10 (2016)YacoubR.KajiD.PatelS.N.SimoesP.K.BusayavalasaD.NadkarniG.N.HeJ.C.CocaS.G.UribarriJ.Association between probiotic and yogurt consumption and kidney disease: insights from NHANESNutr. J.1510201610.1186/s12937-016-0127-3472878926818246Search in Google Scholar
Zhuang L., Chen H., Zhang S., Zhuang J., Li Q., Feng Z.: Intestinal Microbiota in Early Life and Its Implications on Childhood Health. Genomics Proteomics Bioinformatics, DOI: 10.1016/j.gpb.2018.10.002ZhuangL.ChenH.ZhangS.ZhuangJ.LiQ.FengZ.Intestinal Microbiota in Early Life and Its Implications on Childhood HealthGenomics Proteomics BioinformaticsDOI:10.1016/j.gpb.2018.10.002652247530986482Open DOISearch in Google Scholar
